Health ❯ Healthcare

Medicine

Oncology Pharmacology Neurology Pharmaceuticals Clinical Research Cardiology Ethics Patient Care Injuries Endocrinology

FDA Clears All-Oral Decitabine/Cedazuridine Plus Venetoclax for Older AML Patients

The ruling gives unfit, newly diagnosed patients a home-based alternative that still demands vigilant safety oversight.

Meta-Analysis Backs Low-Dose Digitalis for Heart Failure With Fewer Worsening Events

Testosterone Loss Linked to Faster Glioblastoma Growth in Men

FDA Panel Rejects AstraZeneca Breast Cancer Drug, Backs Prostate Therapy

Revolution Medicines’ Pancreatic Cancer Drug Lands ASCO Plenary After Phase 3 Survival Gain

Major Review Says New Alzheimer’s Antibodies Offer No Meaningful Benefit

Metformin Triggers Exercise-Linked Signal in Prostate Cancer Patients

Jitendra Singh Receives MV Lifetime Achievement Award at Inaugural MVCON 2026 in Chennai

Pfizer’s Talzenna Plus Xtandi Delivers Phase 3 Win in Hormone-Sensitive Prostate Cancer

Oncolytic Viruses Trigger T‑Cell Infiltration and Survival Signals in Early Glioblastoma Trials

Lancet Review Finds No Link Between Prenatal Tylenol Use and Autism, ADHD or Intellectual Disability

Largest Review Finds No Link Between Prenatal Acetaminophen and Autism or ADHD

Lancet Meta-Analysis Finds No Neurodevelopmental Risk From Paracetamol in Pregnancy

Tecvayli Cuts Progression Risk 71% and Deaths 40% in Phase 3 Myeloma Trial

Punjab Enforces Hospital Phone Ban, Expands Surveillance Under New Health Department Order

Statins Cut Deaths and Major Cardiac Events Across Risk Levels in Type 2 Diabetes

Der Medicus 2 Opens in Germany After 12-Year Wait

UK Doctor Warns Digoxin Patients To Avoid Black Liquorice

Teclistamab–Daratumumab Delivers Major Survival Gains in Relapsed Myeloma, Phase 3 Data Show

Pirtobrutinib Extends First-Line PFS vs BR and Shows Higher Response Rates Than Ibrutinib in CLL/SLL